Ruxolitinib for Therapy of Graft-versus-Host Disease.
Neumann T, Schneidewind L, Weigel M, Plis A, Vaizian R, Schmidt CA, Krüger W.
Neumann T, et al. Among authors: schmidt ca.
Biomed Res Int. 2019 Mar 6;2019:8163780. doi: 10.1155/2019/8163780. eCollection 2019.
Biomed Res Int. 2019.
PMID: 30956985
Free PMC article.